Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Paraneoplastic syndromes: a review].

R Berardi1, G Grilli, E Romagnoli

  • 1Clinica di Oncologia Medica, Azienda Ospedaliero, Università Politecnica delle Marche, Ancona, Italia. rossana.berardi@libero.it

La Clinica Terapeutica
|February 9, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Female sex is not associated with worse surgical outcomes in infective endocarditis: a prospective study disproving a common assumption.

Frontiers in cardiovascular medicine·2026
Same author

Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysis.

ESMO open·2026
Same author

Distinct molecular and clinical aggressiveness in very early-onset metastatic colorectal cancer: survival and genomic divergence between patients aged 30-39 versus 40-49 years.

ESMO open·2026
Same author

Occurrence of third-generation cephalosporin-resistant Escherichia coli in European hedgehogs (Erinaceus europaeus) from a wildlife rescue centre in Lombardy, Northern Italy.

Veterinary research communications·2026
Same author

Baseline neutrophil-to-eosinophil ratio and neutrophil-to-lymphocyte ratio as prognostic markers in patients with unresectable biliary tract cancer treated with gemcitabine-cisplatin-durvalumab: an international, multicentre, retrospective cohort study.

ESMO gastrointestinal oncology·2026
Same author

Inclusive Search for Anomalous Single-Photon Production in MicroBooNE.

Physical review letters·2026

Recognizing paraneoplastic syndromes aids in early cancer diagnosis and patient treatment. Understanding these syndromes is crucial for improving outcomes in oncology, especially for advanced neoplasms.

Area of Science:

  • Oncology
  • Clinical Medicine
  • Medical Research

Background:

  • Modern oncology faces challenges in treating advanced neoplasms.
  • Early diagnosis and effective treatment are critical for improving patient survival rates.
  • Paraneoplastic syndromes represent a key area for advancing cancer care.

Purpose of the Study:

  • To review the main paraneoplastic syndromes.
  • To focus on the clinical aspects of these syndromes.
  • To highlight cancers commonly associated with paraneoplastic syndromes.

Main Methods:

  • Literature review of paraneoplastic syndromes.
  • Analysis of clinical presentations.
  • Correlation of syndromes with specific neoplasms.

Related Experiment Videos

Main Results:

  • Paraneoplastic syndromes can precede overt cancer diagnosis.
  • Identification of key clinical features for various syndromes.
  • Association of specific syndromes with common cancer types.

Conclusions:

  • Knowledge of paraneoplastic syndromes is vital for early cancer detection.
  • Understanding these syndromes can lead to improved patient management and outcomes.
  • Timely recognition of paraneoplastic syndromes offers opportunities for life-saving interventions.